A review of supine position related obstructive sleep apnea: Classification, epidemiology, pathogenesis and treatment.

Obstructive sleep apnea Supine position Supine position avoidance Supine related obstructive sleep apnea Treatment of obstructive sleep apnea

Journal

Sleep medicine reviews
ISSN: 1532-2955
Titre abrégé: Sleep Med Rev
Pays: England
ID NLM: 9804678

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 10 03 2023
revised: 25 08 2023
accepted: 31 08 2023
medline: 27 11 2023
pubmed: 19 9 2023
entrez: 18 9 2023
Statut: ppublish

Résumé

Supine related obstructive sleep apnea (OSA) is the most common clinical and physiological phenotype of OSA. This condition is recognizable by patients, their families and through polysomnographic recordings. Commonly used definitions distinguish the presence of supine related OSA when respiratory events occur at twice the frequency when the patient lies in the supine compared to non-supine sleeping positions. Recent physiology studies have demonstrated that airway obstruction arises more commonly in the supine position particularly at the level of the soft palate and epiglottis. Increased airway collapsibility is reliability observed supine relative to lateral position. To a lesser extent, changes in control of breathing favour less stable ventilation when the supine sleeping posture is adopted. Many treatments have been developed and trialled to help patients avoid sleeping on their back. The last 10 years has seen the emergence of vibrotactile warning devices that are worn on the patients' neck or chest. High quality randomized controlled trial data is accumulating on the efficacy and common pitfalls of the application of these treatments.

Identifiants

pubmed: 37722317
pii: S1087-0792(23)00103-X
doi: 10.1016/j.smrv.2023.101847
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101847

Informations de copyright

Crown Copyright © 2023. Published by Elsevier Ltd. All rights reserved.

Auteurs

Shane A Landry (SA)

Department of Physiology, Biomedical Discovery Institute, Monash University, Melbourne, Australia.

Caroline Beatty (C)

Department of Physiology, Biomedical Discovery Institute, Monash University, Melbourne, Australia.

Luke D J Thomson (LDJ)

Department of Physiology, Biomedical Discovery Institute, Monash University, Melbourne, Australia.

Ai-Ming Wong (AM)

Royal Hobart Hospital (Tasmanian Health Service South), Hobart, Australia; Department of Medicine, University of Tasmania, Hobart, Australia; Monash Lung, Sleep, Allergy, and Immunity, Monash Health, Clayton, Australia; School of Clinical Sciences, Monash University, Melbourne, Australia.

Bradley A Edwards (BA)

Department of Physiology, Biomedical Discovery Institute, Monash University, Melbourne, Australia; Turner Institute for Brain and Mental Health, Monash University, Melbourne, Australia.

Garun S Hamilton (GS)

Monash Lung, Sleep, Allergy, and Immunity, Monash Health, Clayton, Australia; School of Clinical Sciences, Monash University, Melbourne, Australia; Monash Partners - Epworth, Victoria, Australia.

Simon A Joosten (SA)

Monash Lung, Sleep, Allergy, and Immunity, Monash Health, Clayton, Australia; School of Clinical Sciences, Monash University, Melbourne, Australia; Monash Partners - Epworth, Victoria, Australia. Electronic address: drjoosten@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH